Thrombotic disease

Overview

Thrombotic disease encompasses conditions where blood abnormally coagulates to form a thrombus, or where a thrombus fails to be properly dissolved, leading to blockage of blood vessels.

Representative symptoms include pain, swelling, and warmth in the legs or arms; shortness of breath and chest pain in pulmonary embolism; and speech/vision abnormalities and weakness in one arm or leg in cerebral vascular involvement.

How the Disease Works

Thrombi are related to the process of platelets, blood proteins, and blood cells adhering to one another, and contributing factors may include cancer, surgery, injury, pregnancy, certain medications, and prolonged immobility.

Normally, a thrombus that has stopped bleeding dissolves after healing, but abnormally formed thrombi can block blood flow or detach and travel to other organs.

Presentation Varies by Individual

Thrombosis risk may vary depending on obesity, smoking, diabetes, atrial fibrillation, atherosclerosis, cancer, family history of thrombosis, specific genetic disorders, surgery, and prolonged immobility.

The broad framework for diagnosis and management

Symptoms and course vary greatly depending on the location and size of the thrombus; although symptoms may not be distinct, organ function can be impaired due to blood flow obstruction.

Diagnosis is based on symptoms, medical history, and physical examination, combining blood tests such as D-dimer with imaging tests such as ultrasound, CT, and angiography when necessary.

Current status of treatment

Since D-dimer and imaging tests each have limitations, test results must be interpreted in conjunction with symptoms, the timing of the test, and the possibility of other diseases.

Management focuses on selecting anticoagulants, thrombolytic agents, or thrombectomy procedures by considering the location and severity of the thrombus and the risk of bleeding, with an emphasis on reducing the risk of additional thrombi and complications.

Clinical treatment centers on tailored anticoagulation, and in cases where the thrombus is severe or threatens organ function, thrombolytic agents or procedures may be considered.

How to interpret clinical trials

Clinical trial registration information only indicates the study design and the fact of registration; it does not demonstrate efficacy, safety, approval, or standard of care. Therefore, study results and methods must be verified separately.

Key points to verify in clinical consultations

In clinical practice, the timing and location of symptom onset, recent surgery, hospitalization, long-distance travel, or pregnancy status, current medications, and history of bleeding and family history should be assessed; if sudden dyspnea, chest pain, unilateral paralysis, or difficulty speaking occurs, immediate assistance from the local emergency medical system or medical staff must be sought.